Beta Drugs NSE
1030.00 00.00 (1.04%)
Company Valuation
Market Cap (Rs Cr.) | 985.41 |
Book Value (Rs) | 100.12 |
Face Value (Rs) | 10.00 |
P/E ratio | 52.38 |
Dividend Yield | 0.0 % |
Ownership & Shareholding
Company Ownership
Shareholding Pattern
Sector
Sector | Pharmaceuticals |
Sub Sector | - |
Company Classification | Smallcap |
Exchange Scrips
BSE | sec_id |
NSE | sec_id |
ISIN | INE351Y01019 |
Name | Current Value | Change |
Beta Drugs share has a market capitalization of 985.41 as of today. The share is trading at and has moved by 0.00% in the last year, 0.00% in the last 3 years, and 0.00% in the last 5 years.
Beta Drugs has a P/E ratio of 52.38 as of today. You can check the latest P/E ratio of Beta Drugs and all other listed stocks on Dhan. Open a demat account now!
The ownership stake of Beta Drugs is split as follows:
Make informed investing decisions by viewing shareholding patterns on Dhan Stock Trading App or Web Trading Platform Now!
You can use the Dhan App or Web to start fundamental analysis and invest in Beta Drugs share. Begin with free demat account opening and then add money. Search for a stock that you want to analyze, like Beta Drugs. Tap on the “Fundamentals” tab and view all pertinent information in one place.
Beta Drugs Fundamental Analysis offers an overview of the company's Market Capitalization, Book Value, P/E Ratio, Dividend Yield and more. It helps to analyse the company's fundamental position and its current shareholding pattern and historical shareholding movement. Presently, the current market cap of Beta Drugs is Rs. 985.41. The Face Value and Book Value per share are Rs. 10.00 and Rs. 100.12 respectively. Current P/E ratio of Beta Drugs stands at 52.38. The promoters holding in the company stands at , while Domestic Institutions stand at 00.00% and Foreign Institutions hold 00.00. While understanding and analysing Fundamentals of a company is very crucial, it is equally important to look at the Share Price, Stock Performance, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.